Mike Camilla, Vice President, Investor Relations, Abbott Laboratories: Good morning, and thank you for joining us. With me today are Robert Ford, Chairman and Chief Executive Officer and Phil ...

Mike Comilla-- Vice President, Investor Relations Good morning ... The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool has a disclosure policy.

Abbott (ABT) is one of the stocks most watched ... And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward.

On January 22, Abbott Laboratories published financial ... the impact of Trump's "America First" policy on relations with Europe and China, as investors will continue to focus on stocks with ...

The main point of investing for the long term is to make money. But more than that, you probably want to see it rise more than the market average. But Abbott Laboratories (NYSE:ABT) has fallen short ...

Mike Comilla-- Vice President, Investor Relations Good morning ... are the 10 best stocks for investors to buy now… and Abbott Laboratories wasn’t one of them. The 10 stocks that made the ...

investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term ...

It cannot be recorded or rebroadcast without Abbott’s express written permission. I would now like to introduce Mr. Mike Comilla, Vice President, Investor Relations. Good morning and thank you ...